E Kirches

Summary

Affiliation: Otto-von-Guericke University
Country: Germany

Publications

  1. ncbi Mitochondrial tRNA(Cys) mutation A5823G in a patient with motor neuron disease and temporal lobe epilepsy
    E Kirches
    Institut for Neuropathologie, Universität Magdeburg, Magdeburg, Deutschland
    Pathobiology 67:214-8. 1999
  2. ncbi Expression of matrix metalloproteinases in a series of 12 meningiomas
    E Kirches
    Institute for Neuropathology of the University of Magdeburg, Germany
    Clin Neuropathol 20:26-30. 2001
  3. ncbi Heterogeneous tissue distribution of a mitochondrial DNA polymorphism in heteroplasmic subjects without mitochondrial disorders
    E Kirches
    Institute of Neuropathology, Otto von Guericke University, Leipziger Strasse 44, 39120 Magdeburg, Germany
    J Med Genet 38:312-7. 2001
  4. ncbi High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples
    E Kirches
    Department of Neuropathology, University of Magdeburg, Magdeburg, Germany
    Int J Cancer 93:534-8. 2001
  5. ncbi Comparison between mitochondrial DNA sequences in low grade astrocytomas and corresponding blood samples
    E Kirches
    Department of Neuropathology, University of Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Mol Pathol 55:204-6. 2002
  6. ncbi 2-methoxyestradiol as a potential cytostatic drug in gliomas?
    E Kirches
    Institute of Neuropathology, Otto von Guericke University, Leipziger Str 44, 39120 Magdeburg, Germany
    Anticancer Agents Med Chem 9:55-65. 2009
  7. ncbi Short incubation with 2-methoxyestradiol kills malignant glioma cells independent of death receptor 5 upregulation
    S Braeuninger
    Institute of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Clin Neuropathol 24:175-83. 2005
  8. ncbi Glutathione depletion in antioxidant defense of differentiated NT2-LHON cybrids
    S Schoeler
    Department of Neuropathology, Leipziger Str 44, 39120 Magdeburg, Germany
    Neurobiol Dis 25:536-44. 2007
  9. ncbi Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide
    C Mawrin
    Department of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    J Neurooncol 55:11-7. 2001
  10. ncbi Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton
    K Chamaon
    Department of Neuropathology, University of Magdeburg, Magdeburg, Germany
    J Neurooncol 72:11-6. 2005

Collaborators

Detail Information

Publications27

  1. ncbi Mitochondrial tRNA(Cys) mutation A5823G in a patient with motor neuron disease and temporal lobe epilepsy
    E Kirches
    Institut for Neuropathologie, Universität Magdeburg, Magdeburg, Deutschland
    Pathobiology 67:214-8. 1999
    ..Since this rare mutation affected a nonconserved base position and was not observed in MND or TLE materials, its relation to disease remains unclear...
  2. ncbi Expression of matrix metalloproteinases in a series of 12 meningiomas
    E Kirches
    Institute for Neuropathology of the University of Magdeburg, Germany
    Clin Neuropathol 20:26-30. 2001
    ..Therefore, other mechanisms must be responsible for extracellular matrix degradation at least in a fraction of meningiomas...
  3. ncbi Heterogeneous tissue distribution of a mitochondrial DNA polymorphism in heteroplasmic subjects without mitochondrial disorders
    E Kirches
    Institute of Neuropathology, Otto von Guericke University, Leipziger Strasse 44, 39120 Magdeburg, Germany
    J Med Genet 38:312-7. 2001
    ..The same mutation may cause various diseases, probably because of a different tissue distribution...
  4. ncbi High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples
    E Kirches
    Department of Neuropathology, University of Magdeburg, Magdeburg, Germany
    Int J Cancer 93:534-8. 2001
    ..Our data suggest that the same mechanisms that generate inherited mtDNA polymorphisms are strongly enhanced in gliomas and produce somatic mutations...
  5. ncbi Comparison between mitochondrial DNA sequences in low grade astrocytomas and corresponding blood samples
    E Kirches
    Department of Neuropathology, University of Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany
    Mol Pathol 55:204-6. 2002
    ..This study was extended by sequencing 10 DNA samples of diffuse astrocytomas (World Health Organisation grade II) and corresponding blood samples...
  6. ncbi 2-methoxyestradiol as a potential cytostatic drug in gliomas?
    E Kirches
    Institute of Neuropathology, Otto von Guericke University, Leipziger Str 44, 39120 Magdeburg, Germany
    Anticancer Agents Med Chem 9:55-65. 2009
    ..They were found to be superior in some animal models of tumor growth and vascularization, following oral application...
  7. ncbi Short incubation with 2-methoxyestradiol kills malignant glioma cells independent of death receptor 5 upregulation
    S Braeuninger
    Institute of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Clin Neuropathol 24:175-83. 2005
    ....
  8. ncbi Glutathione depletion in antioxidant defense of differentiated NT2-LHON cybrids
    S Schoeler
    Department of Neuropathology, Leipziger Str 44, 39120 Magdeburg, Germany
    Neurobiol Dis 25:536-44. 2007
    ..The activity of the H(2)O(2) degrading enzyme glutathione peroxidase (GPx) and the activities of glutathione reductase (GR) and superoxide dismutase (SOD) were unaffected...
  9. ncbi Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide
    C Mawrin
    Department of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    J Neurooncol 55:11-7. 2001
    ..No mutations in the p53 and PTEN tumor suppressor genes were found; immunoreactivities for p53, PTEN, and EGFR could not be detected...
  10. ncbi Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton
    K Chamaon
    Department of Neuropathology, University of Magdeburg, Magdeburg, Germany
    J Neurooncol 72:11-6. 2005
    ..A round cell morphology occurred in most treated cells, which was not accompanied by a complete destruction of the microtubule network, as it can be observed with other microtubule targeting drugs...
  11. ncbi Increased human polo-like kinase-1 expression in gliomas
    K Dietzmann
    Institute of Neuropathology, Otto von Guericke University of Magdeburg, Germany
    J Neurooncol 53:1-11. 2001
    ..While all inhibitors minimized the cell density, only the PLCy inhibitor clearly lead to a reduced PLK-1 expression in the three cell lines U87MG, U118MG, U138MG...
  12. ncbi Absence of major accumulation of mitochondrial ND5 mutations in Parkinson patient muscle
    S Schoeler
    Institute of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Clin Neuropathol 26:164-8. 2007
    ..Recently, somatic point mutations in a narrow region of the complex I polypeptide ND5 (codons 120 - 150) were suggested to separate PD patients from age-matched controls, using frontal cortex homogenates...
  13. ncbi Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease
    K Winkler-Stuck
    , , Leipziger Strasse 44, D-39120 Magdeburg, Germany
    J Neural Transm 112:499-518. 2005
    ..Our data confirm the previously debated presence of a mild mitochondrial defect in skeletal muscle of patients with PD which is accompanied with an about 1.5 to 2-fold increase of point mutated mtDNA...
  14. ncbi Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton
    A Dietzmann
    Department of Neuropathology, University of Magdeburg, Magdeburg, Germany
    J Neurooncol 65:99-106. 2003
    ..These results prove that EPOs have antiproliferative effects in glioma cells and affect their tubulin cytoskeleton, as it was previously observed in several types of carcinoma cells...
  15. ncbi The G11778A LHON mutation does not enhance ethambutol cytotoxicity in a cybrid model
    R Pommer
    Institute of Neuropathology, Otto von Guericke University Magdeburg, Germany
    Clin Neuropathol 27:414-23. 2008
    ..Moreover, LHON was reported to be elicited by ethambutol in some mutation carriers...
  16. ncbi Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas
    K Chamaon
    Department of Neuropathology, Otto von Guericke University of Magdeburg, Magdeburg, Germany
    Exp Clin Endocrinol Diabetes 118:121-6. 2010
    ..This result was obtained, when all pituitary adenoma samples were included in the statistical calculations, irrespective of their subclassification. Our study suggests a connection between PTTG and IGF-1 in pituitary adenomas...
  17. ncbi Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri
    E Kirches
    Department of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    J Neurooncol 61:1-5. 2003
    ..Taken together, these results support that even distant tumors in a patient with GC can share a common clonal origin. They demonstrate the extraordinary mobility and infiltrative power of these tumor cells...
  18. ncbi Pineal epidermoid coinciding with pineocytoma
    C Mawrin
    Department of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Acta Neurochir (Wien) 145:783-7. 2003
    ..The unique finding of two different types of tumours in the pineal region is evaluated with regard to the histogenesis of epidermoid cysts and pineocytomas...
  19. ncbi PTEN is not altered in sporadic vestibular schwannomas
    Christian Mawrin
    Department of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Histopathology 40:526-30. 2002
    ....
  20. ncbi Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
    T Schneider
    Department of Neurosurgery, Otto-von-Guericke University, Magdeburg, Germany
    J Neurooncol 53:39-46. 2001
    ..As there were no side effects, however, active specific immunization may be considered an alternative in the management of glioblastoma...
  21. ncbi Mitochondrial DNA deletions sensitize cells to apoptosis at low heteroplasmy levels
    S Schoeler
    Institute of Neuropathology of the Otto-von-Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany
    Biochem Biophys Res Commun 332:43-9. 2005
    ..Mitochondrial deletions confer enhanced susceptibility against proapoptotic signals to proliferating cells, which might explain the elimination of deletions from hematopoietic stem cells...
  22. ncbi Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas
    D Kanakis
    Department of Neuropathology, University of Magdeburg, Magdeburg, Germany
    Clin Endocrinol (Oxf) 58:151-5. 2003
    ..PTTG is overexpressed in about 90% of pituitary adenomas. The reason for its overexpression is still unclear...
  23. ncbi Uterine leiomyosarcoma metastatic to the brain stem
    C Mawrin
    Institute of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Arch Gynecol Obstet 266:119-21. 2002
    ..Despite whole-brain irradiation, the patient died due to respiratory arrest. This case illustrates that brain stem metastasis may occur as a rare complication in uterine leiomyosarcoma...
  24. ncbi Effects of phospholipase Cgamma on Polo-like kinase 1 expression in human glioma cells
    K Dietzmann
    Institute of Neuropathology, Otto von Guericke University, Leipziger Strasse 44, 39120 Magdeburg, Germany
    J Cancer Res Clin Oncol 128:265-70. 2002
    ..Therefore, we studied the correlation between PLCgamma activity and PLK-1 expression and determined cell size and proliferation after PLCgamma inhibition in two glioma cell lines and a primary culture of a glioblastoma...
  25. ncbi Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study
    K Dietzmann
    Department of Neuropathology, Medical School, Otto von Guericke University Magdeburg, Germany
    Pathol Res Pract 196:15-21. 2000
    ....
  26. ncbi Spatial and temporal disease progression of adult-onset subacute sclerosing panencephalitis
    C Mawrin
    Department of Neuropathology, Otto von Guericke University, Magdeburg, Germany
    Neurology 58:1568-71. 2002
    ..This case underlines the importance of measles virus migration for the progression of this fatal disorder...
  27. ncbi Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder
    S Sabunciyan
    Department of Pediatrics, Stanley Division of Developmental Neurovirology, Johns Hopkins University, Baltimore, MD, USA
    J Neural Transm 114:665-74. 2007
    ..The effect of premortem agonal factors and medication on mitochondrial dysfunction still needs further elucidation...